Compatibility of hypokalaemia caused by low-dose prednisolone plus abiraterone acetate therapy for metastatic castration-resistant prostate cancer

Compatibility of hypokalaemia caused by low-dose prednisolone plus abiraterone acetate therapy for metastatic castration-resistant prostate cancer

Abstract Background This study aimed to investigate the relationship between low-dose prednisolone (PSL) and the incidence of hypokalaemia at abiraterone acetate (abiraterone) plus PSL combination therapy targeting Japanese patients with metastatic castration-resistant prostate cancer (mCRPC). Metho...

Full description

Saved in:
Bibliographic Details
Main Authors: Shota Torii, Aya Torii-Goto, Tamaki Tanizawa, Takashi Sakakibara, Ryosuke Oguri, Haruka Nagase, Yuri Nakao, Tomoyuki Hirashita, Kuniaki Tanaka, Norio Takimoto, Takahiro Hayashi
Format: Article
Language:English
Published: BMC 2024-11-01
Series:Journal of Pharmaceutical Health Care and Sciences
Subjects:
Metastatic castration-resistant prostate cancer
Abiraterone
Prednisolone
Serum potassium level
Hypokalaemia
Online Access:https://doi.org/10.1186/s40780-024-00391-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s40780-024-00391-5

Similar Items